Search results
Drug, Biotech Stocks' Q4 Earnings Due on Jan 31: NVO, NVS & GSK
Zacks via Yahoo Finance· 3 months agoThe fourth-quarter 2023 reporting cycle of the Medical sector is about to pick up pace this week....
Weekly Upgrades and Downgrades
InvestorPlace via Yahoo Finance· 1 year agoDuring these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking...
Incyte (INCY) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoIncyte Corporation INCY is scheduled to release its second-quarter 2022 results on Aug 2, before the...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 2 years agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
GSK's (GSK) Boostrix Gets FDA Nod for Pertussis in Newborns
Zacks via Yahoo Finance· 2 years agoFollowing FDA approval, GSK's (GSK) Boostrix is the first vaccine in the United States specifically...
Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More
Zacks via Yahoo Finance· 2 years agoThis week, the FDA granted emergency approval to Pfizer PFE and partner BioNTech BNTX and Moderna’s...
Pharma Stock Roundup: End of SNY's Amcenestrant Development, FDA Updates for AZN, GSK
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) ends the development of breast cancer candidate, amcenestrant. Novartis' (NVS) lung...
Gilead (GILD) Up 2.6% in 3 Months: Will the Momentum Continue?
Zacks via Yahoo Finance· 2 years agoShares of Gilead Sciences, Inc. GILD has gained 2.6% in the past three months against the industry’s...
Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?
Zacks via Yahoo Finance· 2 years agoA smart beta exchange traded fund, the WisdomTree International High Dividend ETF (DTH) debuted on...
Alnylam (ALNY) Up More Than 60% in Past 3 Months: Here's Why
Zacks via Yahoo Finance· 2 years agoAlnylam's (ALNY) portfolio of approved drugs is witnessing a strong uptake while its pipeline is...